Harrow Health

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$49,257
$48,939
$34,587
$36,355
Gross Profit
37,239
36,400
24,034
25,053
EBITDA
4,670
2,853
-4,970
-1,676
EBIT
1,324
-347
-8,150
-4,559
Net Income
-4,220
-6,473
-13,565
-9,148
Net Change In Cash
49,257
48,939
34,587
36,355
Free Cash Flow
2,428
-3,153
-4,738
8,493
Cash
72,601
70,968
68,538
74,085
Basic Shares
35,702
35,618
35,469
35,353

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$130,193
$88,595
$72,476
$48,871
Gross Profit
90,553
63,212
54,262
34,408
EBITDA
9,723
-3,203
-10,143
3,491
EBIT
-2,617
-6,868
-12,539
748
Net Income
-24,411
-14,086
-18,007
-3,419
Net Change In Cash
130,193
88,595
72,476
48,871
Cost of Revenue
54,103
37,866
-648
Free Cash Flow
-148,713
-6,068
-23,430
-2,094
Cash
74,085
96,270
42,167
4,101
Basic Shares
32,616
27,460
26,757
25,895

Earnings Calls

Quarter EPS
2024-09-30
-$0.05
2024-06-30
-$0.18
2024-03-31
-$0.38
2023-12-31
-$0.25